Ownership history in Patten Group, Inc. · 43 quarters on record
This page tracks every 13F SEC filing in which Patten Group, Inc. reported a position in AstraZeneca PLC (AZN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 65,406 | -1,015 | -1.5% | 1.11% | $6.0M | $181.96 |
| 2025 Q3 | REDUCED | 66,421 | -71 | -0.1% | 0.99% | $5.1M | $151.86 |
| 2025 Q2 | ADDED | 66,492 | +14,507 | +27.9% | 0.98% | $4.6M | $137.36 |
| 2025 Q1 | ADDED | 51,985 | +692 | +1.3% | 0.88% | $3.8M | $144.48 |
| 2024 Q4 | REDUCED | 51,293 | -1,574 | -3.0% | 0.74% | $3.4M | $126.98 |
| 2024 Q3 | REDUCED | 52,867 | -525 | -1.0% | 0.91% | $4.1M | $150.99 |
| 2024 Q2 | ADDED | 53,392 | +121 | +0.2% | 0.98% | $4.2M | $150.22 |
| 2024 Q1 | REDUCED | 53,271 | -386 | -0.7% | 0.89% | $3.6M | $130.50 |
| 2023 Q4 | REDUCED | 53,657 | -894 | -1.6% | 0.98% | $3.6M | $127.76 |
| 2023 Q3 | REDUCED | 54,551 | -544 | -1.0% | 1.10% | $3.7M | $128.47 |
As of 2025 Q4 — sorted by position size